Management of Upper-Body Myoclonus in a Patient on Clonazepam and Sertraline
First, discontinue sertraline immediately as it is a known cause of drug-induced myoclonus, particularly with prolonged use, and continue clonazepam which is actually the appropriate treatment for myoclonus. 1, 2, 3
Immediate Action: Address Drug-Induced Myoclonus
Your patient's jerky movements are likely drug-induced myoclonus from sertraline, an SSRI with level A evidence for causing this condition 3. This is particularly concerning given:
- Sertraline is documented to cause myoclonus, especially with prolonged treatment 2, 3
- The FDA label explicitly warns about myoclonus as part of serotonin syndrome 1
- SSRIs including sertraline (citalopram, escitalopram, paroxetine, sertraline) have the highest level of evidence for causing myoclonus 3
Critical pitfall: The patient is already on clonazepam, which is actually the correct treatment for myoclonus 4, 5, 6. This suggests the sertraline-induced myoclonus may be overwhelming the therapeutic effect of clonazepam.
Diagnostic Workup Required
Before adjusting treatment, obtain:
- EEG (electroencephalogram) - Essential to determine if this is epileptic myoclonus with time-locked discharges or non-epileptic myoclonus 4
- Look specifically for: cortical discharges, burst-suppression patterns, or rhythmic/periodic activity 4
- Electromyography (EMG) if needed to classify the neurophysiological subtype 5, 7
The normal CT scan rules out structural causes but does not exclude epileptic myoclonus 4.
Treatment Algorithm
Step 1: Discontinue Sertraline
- Taper gradually over 10-14 days to avoid withdrawal symptoms (which can include myoclonus) 8
- Monitor for serotonin discontinuation syndrome: irritability, mood changes, electric shock sensations, confusion 1
Step 2: Optimize Clonazepam Dosing
Clonazepam is the established first-line treatment for most types of myoclonus 4, 9, 5, 6, 7, 10:
- Typical dosing: 0.5-1 mg at bedtime initially 4, 11
- Can increase to higher doses if tolerated and needed 11
- Effective in 90% of myoclonus cases 12, 11
- Works across multiple myoclonus subtypes (cortical, subcortical, segmental) 5, 6, 7, 10
Important caveat: Clonazepam causes sedation 4, which may have been why sertraline was added initially. However, the sedation typically improves with continued use 11.
Step 3: If Myoclonus Persists After Sertraline Discontinuation
Add levetiracetam or valproic acid as these are the most effective agents for cortical myoclonus (the most common type) 4, 5, 6, 7, 10:
- Levetiracetam: Suggested as first-line for cortical myoclonus 10, well-tolerated
- Valproic acid: Highly effective, particularly if EEG shows epileptiform activity 4, 5, 6
- These can be used in combination with clonazepam 4
Step 4: Based on EEG Results
If EEG shows epileptiform discharges or time-locked activity:
- Treat as epileptic myoclonus with valproic acid as primary agent 4
- Add levetiracetam if monotherapy insufficient 4
- Consider propofol or benzodiazepines for refractory cases 4
If EEG is normal (non-epileptic myoclonus):
Key Clinical Considerations
Avoid these common errors:
- Do not add phenytoin - it is often ineffective for myoclonus 9
- Do not use prophylactic antiepileptics without documented seizures 4
- Do not assume all jerking movements are seizures - many are non-epileptic 4, 9
Monitor for:
- Sedation from clonazepam (may need dose timing adjustment - give 1-2 hours before bedtime if morning drowsiness occurs) 11
- Tolerance to clonazepam is rare in clinical practice 11
- Recurrence of myoclonus if sertraline is reintroduced 2
Alternative Antidepressant if Needed
If depression treatment is still required after sertraline discontinuation, consider:
- Bupropion - does not cause myoclonus and is activating 8
- Mirtazapine - less likely to cause movement disorders 8
- Avoid other SSRIs as they share the same risk profile 3
The most likely scenario is that discontinuing sertraline while maintaining clonazepam will resolve the myoclonus within days to weeks 2, 3. The normal brain imaging supports a drug-induced rather than structural etiology.